News
April 22, 2022
This proxy season, SHARE is challenging pharmaceutical lobbying head-on
SHARE will be at the Johnson & Johnson annual meeting on April 28, where shareholders
Read MoreSHARE will be at the Johnson & Johnson annual meeting on April 28, where shareholders
Read MoreSHARE is recommending withholding support for the Board Chairs at mining companies that do not
Read MoreHighlights from the launch of Canada's 2030 Emissions Reduction Plan, outlining impacts on oil &
Read MoreOn Feb 28, SHARE CEO, Kevin Thomas, spoke before the Senate Standing Committee on Human
Read MoreAlmost two years into the pandemic, it is not surprising that many of us are
Read More